Loading video...

Video Failed to Load

Go Home

๐—ก๐—ฎ๐˜๐˜‚๐—ฟ๐—ฎ๐—น ๐——๐—ข๐—˜๐—ฆ๐—ก'๐—ง ๐— ๐—ฒ๐—ฎ๐—ป ๐—ฆ๐—ฎ๐—ณ๐—ฒ: A brilliant piece by Dr. Dr. Mike Varshavski exposing the myths surrounding so-called โ€œnaturalโ€ supplements. Itโ€™s crucial to understand that many grifters are making millions by selling unregulated vitamins and supplements disguised as โ€œnatural products,โ€ despite little to no formal research proving their efficacy or...

13,550 views โ€ข 11 months ago โ€ขvia X (Twitter)

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

The Hidden Crisis in Modern Medicine: A Call for Change Dr. Aseem Malhotra, a renowned cardiologist and outspoken advocate for medical transparency, has sounded the alarm on a deeply troubling crisis in modern medicineโ€”one that claims countless lives and undermines the trust patients place in the healthcare system. Speaking with urgency and clarity, Dr. Malhotra reveals how the pharmaceutical industryโ€™s influence has corrupted the integrity of medical practice, leaving millions of patients uninformed and at risk. His message is a wake-up call: the system is broken, and itโ€™s time for the public to demand accountability. Dr. Malhotra highlights a staggering statistic: prescribed medications are the third leading cause of death globally, trailing only heart disease and cancer. This grim reality, which predates the COVID-19 pandemic, stems not from medical errors but from the side effects of drugs prescribed under a flawed system. Patients, he argues, are not receiving fully informed consent because the information they and their doctors rely on is tainted by bias and corruption. While doctors themselves are not to blameโ€”they are conditioned by a system fed with manipulated dataโ€”the consequences are devastating. At the heart of this crisis lies the pharmaceutical industryโ€™s stranglehold on regulatory bodies. Dr. Malhotra points to the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK, which receives 86% of its funding from the drug industry, and the U.S. Food and Drug Administration (FDA), funded 50-65% by Big Pharma. These agencies, tasked with protecting the public, often fail to independently evaluate the data provided by the very companies they regulate. The result? Drugs are approved and marketed based on incomplete or manipulated evidence, leaving patients vulnerable to harm. Dr. Malhotra doesnโ€™t mince words when describing the pharmaceutical industryโ€™s behavior. As legal entities, he argues, these corporations exhibit psychopathic traits: a callous disregard for safety, an incapacity for guilt, and a pattern of lying and manipulation for profit. He cites the chilling case of Vioxx, a blockbuster painkiller marketed by Merck in the late 1990s. Touted as a safer alternative to ibuprofen, Vioxx was linked to heart attacks and strokesโ€”risks Merckโ€™s executives knew about but concealed. Internal emails uncovered during litigation, as revealed by Dr. John Abramson, a former Harvard physician, showed Merckโ€™s chief scientist acknowledging the cardiovascular risks while callously predicting the drugโ€™s financial success. The toll? An estimated 60,000 deaths in the U.S. alone. Merck was fined nearly $1 billion for fraud, yet no executives faced personal consequences, and the company continued business as usual. Even more shocking, when the FDA instructed Merck to add a black box warning to Vioxxโ€™s packaging to alert the public of its risks, Merck ignored the directive. Instead, they ramped up marketing, purchasing reprints of a New England Journal of Medicine articleโ€”initially suggesting the drugโ€™s safetyโ€”for nearly $1 million. These reprints were used as marketing tools to mislead doctors and patients, doubling down on the false narrative of safety. Dr. Malhotra calls this behavior โ€œnothing short of psychopathic.โ€ This is not an isolated incident. Over decades, pharmaceutical companies have paid billions in fines for hiding data on harms, manipulating research, and engaging in fraudulent practices. The cumulative impact? Millions of lives lost to preventable drug-related harms. Yet, most doctors remain unaware of the extent of this misconduct, relying on guidelines and studies influenced by the same industry. Patients, in turn, are left in the dark, trusting a system that prioritizes profit over safety. Dr. Malhotra emphasizes that change is possibleโ€”and urgently needed. He points to the efforts of Secretary Robert F. Kennedy Jr., Dr. Jay Bhattacharya, and Dr. Marty Makary, the new head of the FDA, who are working to reform the system. Their mission is to restore integrity to medical research and regulation, ensuring that patients receive transparent, evidence-based care. But they cannot do it alone. Dr. Malhotra calls on the public to raise awareness, refuse to stay silent, and demand accountability from regulators, institutions, and the pharmaceutical industry. The path forward requires a collective awakening. By exposing these injustices and supporting leaders who prioritize public health over corporate interests, we can rebuild a medical system that truly serves patients. Dr. Malhotraโ€™s message is clear: the time for complacency is over. Share this truth, make noise, and join the fight for a safer, more ethical future in medicine.

Camus

112,631 views โ€ข 1 year ago

Hyderabad-based paediatrician Sivaranjani Santosh, whose eight-year battle led to a key regulatory shift on ORS labelling, is now facing legal trouble after pharma majors issued a notice accusing her of making false, misleading, disparaging and defamatory remarks about their products. The development comes after the Food Safety and Standards Authority of India (FSSAI), in an order issued in October 2025, stated that no food brand may use the term โ€˜Oral Rehydration Saltsโ€™ or โ€˜ORSโ€™ unless the formulation strictly adheres to standards recommended by the World Health Organisation (WHO). A cease and desist notice dated March 16 alleges that Dr. Santosh made defamatory statements on social media about products, including ORSL and its rebranded version ERZL. The notice states that the companies are science-based and compliant with the Food Safety and Standards Act, 2006, and asserts that their claims are backed by scientific evidence and regulatory approvals. Referring to ongoing regulatory and legal developments, the notice cites proceedings before the Delhi High Court, stating that the court had observed that the products in question were โ€˜not adulterated or unsafe for useโ€™ and that the dispute was limited to branding aspects. The notice denies claims that erstwhile ORSL products continue to be sold or that ERZL is being marketed as an ORS substitute, stating that distributors have been instructed to return or relabel older stock in compliance with FSSAI directions. The companies have demanded that Dr. Santosh immediately remove all allegedly defamatory posts, refrain from making further statements against them or their products, and avoid unauthorised use of their trademarks. Responding through her Instagram page, Dr. Sivaranjani defended her position and questioned the legal notice. She said her position was consistent with and supported by the FSSAI orders issued on October 14 and 15, 2025 and added that the Delhi High Court had refused to grant a stay. She argued that presenting ERZL as a new form of ORSL would violate the regulatory directive and could confuse parents who previously associated ORSL with ORS.

Hate Detector ๐Ÿ”

75,821 views โ€ข 4 months ago

Dr. Sabine Hazan, a renowned gastroenterologist and microbiome expert, revealed a disturbing truth about the vitamin industry that demands attention. Her research during the pandemic uncovered a critical issue: not all vitamins are created equal, and many could be undermining your health. The problem lies in manufacturing. Some vitamins, particularly those produced overseas, are contaminated with heavy metals like copper and arsenic. Aging factory equipment, such as corroded copper pipes and outdated machinery, allows these toxins to seep into the supplements you take daily. These contaminants can devastate your gut microbiome, killing off beneficial bacteria like bifidobacteria essential for good health. Determined to find a solution, Dr. Hazan partnered with a trusted American company to create a pure Vitamin C supplement, free from toxic metals. She chose an American manufacturer because U.S. standards ensure cleaner, safer products. In her studies, she tested this vitamin on patients, measuring their microbiome before and after. The result was a significant increase in bifidobacteria, confirming the effectiveness of a high-quality, controlled supplement. Had she used random, unverified vitamins, the outcomes would have been inconsistent. Contaminated supplements donโ€™t just fail to deliver benefitsโ€”they actively harm your gut by disrupting its delicate balance. Dr. Hazanโ€™s research underscores a critical point: the source of your vitamins is as important as the vitamin itself. Key Takeaways from Dr. Hazanโ€™s Research: - Contaminated vitamins, often from overseas, contain heavy metals that damage gut health. - American-made vitamins are generally purer due to stricter manufacturing standards. - Pure, high-quality vitamins, like her tested Vitamin C, can boost beneficial gut bacteria. - Always choose trusted, verified brands to protect your microbiome. The bottom line: your health is too valuable to risk on cheap, unvetted supplements. Demand transparency, quality, and American-made products to safeguard your gut and overall well-being. Share this post to raise awareness! Letโ€™s hold the supplement industry accountable and prioritize health over profit.

Camus

13,008 views โ€ข 1 year ago

Dr. Byram Bridle sheds light on the promising potential of ivermectin and fenbendazole in cancer treatment. These affordable, off-patent drugsโ€”originally used as dewormersโ€”have shown early-stage research indicating benefits across a wide range of cancer types. However, the medical community demands randomized controlled trials (RCTs) to validate their efficacy. The challenge? RCTs cost millions, typically funded by pharmaceutical companies. But with no profit to be made from cheap, off-patent drugs like ivermectin and fenbendazole, Big Pharma has little incentive to invest. Dr. Bridle argues this creates a systemic barrier, preventing these potentially game-changing treatments from entering mainstream oncology Dr. Bridle, who has extensively reviewed the literature, calls the early research โ€œfantasticโ€ and urges government intervention. He advocates for taxpayer-funded RCTs to bridge the gap, emphasizing that public investment could unlock these drugsโ€™ potential to transform cancer care. However, Dr. Bridle raises a deeper concern about the cancer industry. At a pharmaceutical-sponsored conference, he was shocked to hear business leaders describe their โ€œidealโ€ cancer treatment: not a cure, but a lifelong, expensive patented drug that keeps cancer cells at bay while maintaining quality of life. This profit-driven mindset, he notes, clashes with the publicโ€™s expectation of curative intent. Dr. Bridle questions whether the cancer industry truly prioritizes finding a cure, given the immense financial stakes. His insights highlight a critical need for reform to prioritize patients over profits

Joe Tippens

34,201 views โ€ข 1 year ago